A Novel Method for Qualification of a Potency Assay through Partial Computer Simulation

Reference

1. 1.↵
   1. Gottschalk P. J.,
   2. Dunn J. R.

   Measuring Parallelism, Linearity, and Relative Potency in Bioassay and Immunoassay Data. J. Biopharm. Stat. 2005, 15 (3), 437–463

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Yang H.,
   2. Kim H. J.,
   3. Zhang L.,
   4. Strouse R. J.,
   5. Schenerman M.,
   6. Jiang X. R.

   Implementation of Parallelism Testing for Four-Parameter Logistic Model in Bioassays. PDA J. Pharm. Sci. Technol. 2012, 66 (3), 262–269.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Yang H.,
   2. Zhang L.

   Evaluations of parallelism testing methods using ROC analysis”. Stat. Biopharm. Res. 2012, 66 (3), 262–269.

   OpenUrl
4. 4.↵
   1. Novick S.,
   2. Yang H.,
   3. Peterson J.

   A Bayesian Approach to Parallelism Testing in Bioassay. Stat. Biopharm. Res. 2012, 4 (4), 357–374.

   OpenUrl
5. 5.↵
   United States Pharmacopeia (USP) Chapter <1032> Design and Development of Biological Assay; USP Pharmacopeial Convention, Inc.: Rockville, MD, 2012.
6. 6.↵
   United States Pharmacopeia (USP) Chapter <111> Design and Analysis of Biological Assays; USP Pharmacopeial Convention, Inc.: Rockville, MD, 2003.
7. 7.↵
   United States Pharmacopeia (USP) Chapter <1225>: Validation of Compendal Procedures; USP Pharmacopeial Convention, Inc.: Rockville, MD, 2017.
8. 8.↵
   International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use Topic Q2(R1): Validation of Analytical Procedures: Text and Methodology; ICH Harmonized Tripartite, 2005.
9. 9.↵
   Guidance for Industry: Bioanalytical Method Validation; FDA Department of Health and Human Services: Rockville, MD, 2001.
10. 10.↵
    United States Pharmacopeia (USP) Chapter <1033> Biological Assay Validation; USP Pharmacopeial Convention, Inc.: Rockville, MD, 2017.
11. 11.↵
    1. Porter D.

    Qualification, Validation, and Verification. Pharm. Technol. 2007, 31 (4), 146–154.

    OpenUrl
12. 12.↵
    1. Boudreau S. P.,
    2. McElvain J. S.,
    3. Martin L. D.,
    4. Dowling T.,
    5. Fields S. M.

    Method Validation by Phase of Development. Pharm. Technol. 2004, 28 (11), 54–66.

    OpenUrl
13. 13.↵
    1. Finney D. J.

    Statistical Method in Biological Assays, 1st ed.; Charles Griffin & Company: Glasgow, Scotland, 1952; pp 99–136.
14. 14.↵
    United States Pharmacopeia (USP) Chapter <1034> Analysis of Biological Reagents. USP Pharmacopeial Convention, Inc.: Rockville, MD, 2017.
15. 15.↵
    1. Gelman A.,
    2. Carlin J.,
    3. Stern H.,
    4. Dunson D.,
    5. Vehtari A.,
    6. Rubin D.

    Bayesian Data Analysis; Chapman & Hall/CRC Press: Boca Raton, FL, 2013.
16. 16.↵
    R Core Team. R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing: Vienna, Austria, 2016. URL https://www.R-project.org/.
17. 17.↵
    1. Gelman A.,
    2. Hill J.

    Data Analysis Using Regression and Multilevel Hierarchical Models; Cambridge University Press: New York, 2006.
18. 18.↵
    1. Plummer M.

    JAGS: A Program for Analysis of Bayesian Graphical Models Using Gibbs Sampling, Proceedings of the 3^rd International Workshop on Distributed Statistical Computing (DSC 2003), March 20–22, 2003, Vienna, Austria. ISSN 1609-395X.